Agios Pharmaceuticals (AGIO) EBIT Margin Growth (5y) (2017 - 2025)
Analysis
Agios Pharmaceuticals (AGIO) EBIT Margin Growth (5y) (2017 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Agios Pharmaceuticals | 1.97 Bn | 1.97 Bn | 41.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -39,903.00 |
| Sep 30, 2025 | -67,602.00 |
| Jun 30, 2025 | -79,717.00 |
| Mar 31, 2025 | -112,205.00 |
| Dec 31, 2024 | -86,641.00 |
| Sep 30, 2024 | -72,786.00 |
| Jun 30, 2024 | -79,405.00 |
| Mar 31, 2024 | -80,183.00 |
| Dec 31, 2023 | -117,518.00 |
| Sep 30, 2023 | -71,119.00 |
| Jun 30, 2023 | -121,550.00 |
| Mar 31, 2023 | -54,254.00 |
| Dec 31, 2022 | -138,119.00 |
| Sep 30, 2022 | -189,503.00 |
| Jun 30, 2022 | -100,356.00 |
| Mar 31, 2022 | -1.15 Mn |
| Dec 31, 2020 | 32,826.00 |
| Sep 30, 2020 | 50,725.00 |
| Jun 30, 2020 | 2,013.00 |
| Mar 31, 2020 | -8,473.00 |